💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

UPDATE 1-Hearing aid co Amplifon to buy Australia's NHC

Published 09/28/2010, 02:59 AM
Updated 09/28/2010, 03:04 AM

* National Hearing Care valued at $441 million

* Crescent Capital was considering IPO of the business

(adds details)

MILAN, Sept 28 (Reuters) - Hearing aid retailer Amplifon SA has agreed to buy Australia's NHC Group Pty Ltd for A$460 million ($441 million) in cash from its private-equity owner, the Italian company said, heading off a planned IPO.

NHC is a hearing aid distributor with 200 clinics in Australia, New Zealand and India, the statement said. [ID:nBIA283d6]

"This strategic acquisition allows the Amplifon Group to enter an important new geographic market with provides significant potential for growth," Amplifon said.

The owner of National Hearing Care, Australian private equity firm Crescent Capital Partners, had run a dual-track sales process and was heading towards a float of the audiology business, an industry source said earlier this month.

The prospectus for the planned IPO was due to be lodged on Sept. 30 and the shares were due to start trading Oct. 15.

IPOs above A$100 million have been extremely rare in the Australian market this year, with a number of private equity-owned businesses putting float plans on hold until 2011 in the hope that volatile markets will settle.

National Hearing Care runs the largest private audiology practice in Australia with 70 clinics. It expanded into New Zealand in 2008 and opened its first clinics in India this year.

Macquarie and JP Morgan advised Crescent.

The deal is subject to regulatory approval in Australia and New Zealand. (Reporting by Ian Simpson in Milan and Victoria Thieberger in Melbourne; Editing by Mike Nesbit/Ed Davies) ($1=1.042 Australian Dollar)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.